Browse by Person (creator, editor, contributor, etc.)
 | Up a level |
Jump to: Article
Number of items: 2.
Article
| Yap, T. A. and Walton, M. I. and Hunter, L.-J. K. and Valenti, M. and de Haven Brandon, A. and Eve, P. D. and Ruddle, R. and Heaton, S. P. and Henley, A. and Pickard, L. and Vijayaraghavan, G. and Caldwell, J. J. and Thompson, N. T. and Aherne, W. and Raynaud, F. I. and Eccles, S. A. and Workman, P. and Collins, I. and Garrett, Michelle D. (2010) Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930. Molecular Cancer Therapeutics, 10 (2). pp. 360-371. ISSN 1535-7163. (doi:https://doi.org/10.1158/1535-7163.MCT-10-0760) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) |
| Grimshaw, K. M. and Hunter, L.-J. K. and Yap, T. A. and Heaton, S. P. and Walton, M. I. and Woodhead, S. J. and Fazal, L. and Reule, M. and Davies, T. G. and Seavers, L. C. and Lock, V. and Lyons, J. F. and Thompson, N. T. and Workman, P. and Garrett, Michelle D. (2010) AT7867 Is a Potent and Oral Inhibitor of AKT and p70 S6 Kinase That Induces Pharmacodynamic Changes and Inhibits Human Tumor Xenograft Growth. Molecular Cancer Therapeutics, 9 (5). pp. 1100-1110. ISSN 1535-7163. (doi:https://doi.org/10.1158/1535-7163.MCT-09-0986) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) |
